Actos – FDA warns of Increased Risk of Bladder Cancer
Actos (pioglitazone) lawyers within our firm are reviewing potential cases against the Actos manufacturer after the FDA warned that Actos use is linked to an Increased Risk of Bladder Cancer. The FDA Actos findings can be read here: http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm
Actos, known as Pioglitazone has been sold under the brand name Actos or in combination with metformin as Actoplus Mext XR and glimepiride as Duetact. The drug is intended to treat diabetes.
If you or a loved on has been diagnosed with Bladder Cancer and have taken Actos, a diabetes medication, please contact us for free legal advice and free legal Actos information concerning the potential for an Actos lawsuit. At Fears | Nachawati, our Actos lawyers are experienced defective drug lawyers. Call us at 1.866.545.8364 or by email at email@example.com.